Salesforce Raised Guidance Again. Now It Has to Deliver the Revenue Acceleration
Salesforce (CRM) reported Q2 revenue of $11.35B, beating estimates, and raised FY2027 guidance to $46.1B-$46.4B. Argus raised its price target to $300. Growth is driven by AI tools like Agentforce and strategic investments, though organic growth remains modest. Hedge funds hold positions, but short interest is low.
How this was made

The 30-second read
Why it matters
The earnings beat and guidance lift provide a fresh catalyst for price action, with analysts upgrading targets.
Market read
Strong earnings and guidance raise make Salesforce a near‑term bullish play in the AI‑driven SaaS space.
What to watch
FX headwind and high short interest could limit upside if AI adoption stalls.
Background
Salesforce's Q2 results beat estimates, with AI revenue growth and a second guidance raise for FY2027.
Ticker impact
Salesforce reported Q2 revenue beat and raised full-year FY2027 guidance to $46.1‑$46.4B, prompting a 20%+ stock rally.
Potential upside of 10‑15% over the next few weeks if guidance holds.
Large-cap earnings beat plus guidance lift is a material catalyst; analyst price target raised to $300.
Market effects
AI‑enabled SaaS firms may see heightened investor interest as Salesforce's AI suite gains traction.
U.S. tech sector likely to benefit from the upbeat earnings and guidance.
Reinforces broader AI adoption narrative across global markets.
Counterpoint
Guidance lift relies heavily on acquisitions; organic growth is modest, raising execution risk.
Key entities
- companySalesforce Inc.
Cloud‑software provider reporting Q2 results and raising FY2027 revenue guidance.
- analyst_firmArgus
Raised Salesforce price target to $300.





